Health
Decrease in serum antibodies to SARS‐CoV‐2 in convalescent plasma donors over time – Wiley
Click on the article title to read more.
To the Editor
Convalescent plasma, collected from donors who have previously recovered from viral illnesses, has been used to treat patients with a variety of emerging infectious diseases. This product has become more prominent during the current COVID19 pandemic, including with the recent emergency use authorization from the Food and Drug Administration, but the longevity of SARSCoV2 antibodies in donated plasma is unknown. Historically, convalescent plasma has been used to reduce mortality in…
-
Business23 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News22 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General17 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News19 hours agoTips to improve engagement – Proctor